Nüssler V - Search Results

1

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.

Nüssler V, Pelka-Fleischer R, Zwierzina H, Nerl C, Beckert B, Gullis E, Gieseler F, Bock S, Bartl R, Petrides PE, et al. Nüssler V, et al. Ann Hematol. 1994;69 Suppl 1:S25-9. doi: 10.1007/BF01757351. Ann Hematol. 1994. PMID: 7914749

2

P-glycoprotein expression in patients with acute leukemia-clinical relevance.

Nüssler V, Pelka-Fleischer R, Zwierzina H, Nerl C, Beckert B, Gieseler F, Diem H, Ledderose G, Gullis E, Sauer H, Wilmanns W. Nüssler V, et al. Leukemia. 1996 Jul;10 Suppl 3:S23-S31. Leukemia. 1996. PMID: 8656697

3

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.

Nüssler V, Gieseler F, Zwierzina H, Gullis E, Pelka-Fleischer R, Diem H, Abenhardt W, Schmitt R, Langenmayer I, Wohlrab A, Kolb HJ, Wilmanns W. Nüssler V, et al. Ann Hematol. 1997 Feb;74(2):57-64. doi: 10.1007/s002770050258. Ann Hematol. 1997. PMID: 9063374

4

Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia.

Nüssler V, Sauer H, Pelka-Fleischer R, Hölzel D, Wilmanns W. Nüssler V, et al. Eur J Haematol. 1990 Jul;45(1):19-25. doi: 10.1111/j.1600-0609.1990.tb00409.x. Eur J Haematol. 1990. PMID: 2379561

5

Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia.

Stoetzer OJ, Nüssler V, Darsow M, Gullis E, Pelka-Fleischer R, Scheel U, Wilmanns W. Stoetzer OJ, et al. Among authors: nussler v. Leukemia. 1996 Jul;10 Suppl 3:S18-S22. Leukemia. 1996. PMID: 8656695

6

In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.

Nüssler V, Pelka-Fleisc R, Gieseler F, Hasmann M, Löser R, Gullis E, Stötzer O, Zwierzina H, Wilmanns W. Nüssler V, et al. Leuk Lymphoma. 1998 Nov;31(5-6):589-97. doi: 10.3109/10428199809057619. Leuk Lymphoma. 1998. PMID: 9922050

7

Cellular resistance mechanisms with impact on the therapy of multiple myeloma.

Gieseler F, Nüssler V. Gieseler F, et al. Among authors: nussler v. Leukemia. 1997 Dec;11 Suppl 5:S1-4. Leukemia. 1997. PMID: 9436930 Review.

8

Cellular resistance mechanisms with impact on the therapy of multiple myeloma.

Gieseler F, Nüssler V. Gieseler F, et al. Among authors: nussler v. Leukemia. 1998 Jul;12(7):1009-12. doi: 10.1038/sj.leu.2401060. Leukemia. 1998. PMID: 9665183 Review.

9

Drug-induced apoptosis in chronic lymphocytic leukemia.

Stoetzer OJ, Pogrebniak A, Scholz M, Pelka-Fleischer R, Gullis E, Darsow M, Nüssler V, Wilmanns W. Stoetzer OJ, et al. Among authors: nussler v. Leukemia. 1999 Nov;13(11):1873-80. doi: 10.1038/sj.leu.2401572. Leukemia. 1999. PMID: 10557065

10

Cytotoxicity of anthracyclines: correlation with cellular uptake, intracellular distribution and DNA binding.

Gieseler F, Biersack H, Brieden T, Manderscheid J, Nüssler V. Gieseler F, et al. Among authors: nussler v. Ann Hematol. 1994;69 Suppl 1:S13-7. doi: 10.1007/BF01757349. Ann Hematol. 1994. PMID: 8061108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters